This large, contemporary study reports the management of anemia in a real-world cohort of >26,000 patients with NDD-CKD from multifaceted aspects, including a cross-sectional study of anemia treatment on initial Hb response and Hb fluctuations to provide comprehensive epidemiologic information on anemia management in routine clinical care. Here, GSTM1 is linked to chronic kidney disease.